Compare The Cooper Cos., Inc. with Similar Stocks
Dashboard
1
Poor long term growth as Operating profit has grown by an annual rate 14.01% of over the last 5 years
2
With a growth in Operating Profit of 9.01%, the company declared Very Positive results in Apr 26
3
With ROCE of 6.65%, it has a very expensive valuation with a 1.52 Enterprise value to Capital Employed
4
High Institutional Holdings at 100%
5
Consistent Underperformance against the benchmark over the last 3 years
Stock DNA
Pharmaceuticals & Biotechnology
USD 13,920 Million (Small Cap)
35.00
NA
0.00%
0.28
4.80%
1.66
Revenue and Profits:
Net Sales:
1,082 Million
(Quarterly Results - Apr 2026)
Net Profit:
-78 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-7.39%
0%
-7.39%
6 Months
-20.07%
0%
-20.07%
1 Year
-5.59%
0%
-5.59%
2 Years
-28.09%
0%
-28.09%
3 Years
-82.06%
0%
-82.06%
4 Years
-78.39%
0%
-78.39%
5 Years
-82.83%
0%
-82.83%
The Cooper Cos., Inc. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
10.99%
EBIT Growth (5y)
14.01%
EBIT to Interest (avg)
9.81
Debt to EBITDA (avg)
2.54
Net Debt to Equity (avg)
0.30
Sales to Capital Employed (avg)
0.37
Tax Ratio
34.26%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
5.85%
ROE (avg)
13.03%
Valuation key factors
Factor
Value
P/E Ratio
35
Industry P/E
Price to Book Value
1.66
EV to EBIT
22.83
EV to EBITDA
16.29
EV to Capital Employed
1.52
EV to Sales
3.92
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
6.65%
ROE (Latest)
4.80%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
Bullish
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Mildly Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
No Trend
Shareholding Snapshot : Apr 2026
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 134 Schemes (53.88%)
Foreign Institutions
Held by 377 Foreign Institutions (27.92%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - Apr'26 - QoQ
Apr'26
Jan'26
Change(%)
Net Sales
1,081.50
1,024.10
5.60%
Operating Profit (PBDIT) excl Other Income
336.00
308.30
8.98%
Interest
26.20
28.60
-8.39%
Exceptional Items
-271.60
0.00
Consolidate Net Profit
-77.90
130.80
-159.56%
Operating Profit Margin (Excl OI)
222.50%
207.80%
1.47%
USD in Million.
Net Sales
QoQ Growth in quarter ended Apr 2026 is 5.60% vs -3.86% in Jan 2026
Consolidated Net Profit
QoQ Growth in quarter ended Apr 2026 is -159.56% vs 54.61% in Jan 2026
Annual Results Snapshot (Consolidated) - Oct'25
Oct'25
Oct'24
Change(%)
Net Sales
4,092.40
3,895.40
5.06%
Operating Profit (PBDIT) excl Other Income
1,105.90
1,119.50
-1.21%
Interest
63.90
59.30
7.76%
Exceptional Items
0.00
0.00
Consolidate Net Profit
374.90
392.30
-4.44%
Operating Profit Margin (Excl OI)
166.90%
181.20%
-1.43%
USD in Million.
Net Sales
YoY Growth in year ended Oct 2025 is 5.06% vs 8.41% in Oct 2024
Consolidated Net Profit
YoY Growth in year ended Oct 2025 is -4.44% vs 33.34% in Oct 2024
About The Cooper Cos., Inc. 
The Cooper Cos., Inc.
Pharmaceuticals & Biotechnology
The Cooper Companies, Inc. is a global medical device company. The Company operates through two business units: CooperVision, Inc. and CooperSurgical, Inc. CooperVision offers soft contact lenses for the vision correction market. CooperVision develops, manufactures and markets a range of single-use, two-week and monthly contact lenses. CooperVision services three primary regions: the Americas; Europe, the Middle East and Africa (EMEA), and Asia Pacific. CooperVision offers spherical, aspherical, toric, multifocal and toric multifocal lens products in various modalities. CooperVision's products are primarily manufactured at its facilities located in the United Kingdom, Puerto Rico, Hungary, Costa Rica and New York. CooperSurgical offers an array of products and services focused on advancing the health of families through a portfolio of products and services focusing on women's health, fertility and diagnostics.
Company Coordinates 
Company Details
6101 Bollinger Canyon Rd Ste 500 , SAN RAMON CA : 94583-5177
Registrar Details






